Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

William Ho Biography and Net Worth

Insider of RAPT Therapeutics

Bill joined RAPT Therapeutics as Chief Medical Officer in 2015, bringing with him extensive experience both in clinical immunotherapy and in the translational and clinical development of novel therapeutics to treat cancer. He joined RAPT Therapeutics after serving as the Vice President of Clinical Development at Igenica Biotherapeutics, where he led the clinical development of antibody-based therapeutics. Prior to Igenica, Bill served as a Senior Medical Director in the Exploratory Clinical Development (BioOncology) group at Genentech, where for seven years he led the development of multiple small molecule, antibody, and antibody-drug conjugate programs from IND filing to Phase III, including clinical development of Gazyva® (obinutuzumab), Venclexta™ (venetoclax) and Polivy™ (polatuzumab vedotin-piiq).

Bill received his A.B. in Molecular Biology from Princeton University and both his M.D. and his Ph.D. in Microbiology and Immunology from the Stanford University School of Medicine, where he studied cellular immunology in the laboratory of Mark Davis, Ph.D. Bill completed his internship and residency in Internal Medicine at the University of California, San Francisco, and received his training in Medical Oncology at the University of Washington and Fred Hutchinson Cancer Research Center, where he studied adoptive immunotherapy methods to treat leukemia.

What is William Ho's net worth?: The estimated net worth of William Ho is at least $16,221.60 as of December 21st, 2023. Dr. Ho owns 15,020 shares of RAPT Therapeutics stock worth more than $16,222 as of November 23rd. This net worth estimate does not reflect any other investments that Dr. Ho may own. Additionally, Dr. Ho receives a salary of $620,320.00 as Insider at RAPT Therapeutics. Learn More about William Ho's net worth.
How old is William Ho?: Dr. Ho is currently 58 years old. There are 6 older executives and no younger executives at RAPT Therapeutics. The oldest executive at RAPT Therapeutics is Dr. David Wustrow, Senior Vice President of Drug Discovery & Preclinical Development, who is 65 years old. Learn More on William Ho's age.
What is William Ho's salary?: As the Insider of RAPT Therapeutics, Inc., Dr. Ho earns $620,320.00 per year. The highest earning executive at RAPT Therapeutics is Dr. Brian Russell Wong M.D., Ph.D., CEO, President & Director, who commands a salary of $861,240.00 per year. Learn More on William Ho's salary.
How do I contact William Ho?: The corporate mailing address for Dr. Ho and other RAPT Therapeutics executives is 561 ECCLES AVENUE, SOUTH SAN FRANCISCO CA, 94080. RAPT Therapeutics can also be reached via phone at (650) 489-9000 and via email at [email protected]. Learn More on William Ho's contact information.
Has William Ho been buying or selling shares of RAPT Therapeutics?: William Ho has not been actively trading shares of RAPT Therapeutics during the past quarter. Most recently, William Ho sold 2,500 shares of the business's stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $21.68, for a transaction totalling $54,200.00. Following the completion of the sale, the insider now directly owns 15,020 shares of the company's stock, valued at $325,633.60. Learn More on William Ho's trading history.
Who are RAPT Therapeutics' active insiders?: RAPT Therapeutics' insider roster includes Dirk Brockstedt (Insider), William Ho (Insider), and Wendye Robbins (Director). Learn More on RAPT Therapeutics' active insiders.
Are insiders buying or selling shares of RAPT Therapeutics?: In the last twelve months, insiders at the sold shares 3 times. They sold a total of 4,898 shares worth more than $95,236.44. The most recent insider tranaction occured on January, 5th when insider Dirk G Brockstedt sold 898 shares worth more than $20,456.44. Insiders at RAPT Therapeutics own 6.6% of the company. Learn More about insider trades at RAPT Therapeutics.
Information on this page was last updated on 1/5/2024.

William Ho Insider Trading History at RAPT Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/21/2023	Sell	2,500	$21.68	$54,200.00	15,020
11/28/2023	Sell	1,500	$13.72	$20,580.00	17,520
10/3/2023	Sell	2,500	$15.77	$39,425.00	18,789
8/18/2023	Sell	2,500	$18.92	$47,300.00	21,289
4/19/2023	Sell	5,000	$18.88	$94,400.00	20,992
3/7/2023	Sell	5,000	$29.62	$148,100.00	25,532
1/24/2023	Sell	5,000	$30.00	$150,000.00	30,072
1/19/2023	Sell	5,000	$25.56	$127,800.00	35,072
12/29/2022	Sell	5,000	$18.03	$90,150.00	37,650
11/28/2022	Sell	5,000	$17.87	$89,350.00	42,650
11/2/2022	Sell	5,000	$22.32	$111,600.00	47,650
10/13/2022	Sell	2,000	$21.52	$43,040.00	52,650
8/30/2022	Sell	2,500	$28.13	$70,325.00	53,035
7/11/2022	Sell	2,000	$19.95	$39,900.00	52,306
4/6/2022	Sell	3,000	$22.96	$68,880.00
2/28/2022	Sell	3,000	$18.79	$56,370.00
1/13/2022	Sell	3,000	$30.67	$92,010.00
1/5/2022	Sell	2,000	$40.00	$80,000.00
12/3/2021	Sell	3,000	$32.26	$96,780.00
10/13/2021	Sell	3,000	$29.69	$89,070.00
9/20/2021	Sell	2,000	$40.00	$80,000.00
9/17/2021	Sell	2,000	$38.97	$77,940.00
9/8/2021	Sell	3,000	$36.04	$108,120.00
8/16/2021	Sell	1,000	$32.07	$32,070.00
8/2/2021	Sell	1,000	$30.52	$30,520.00
7/15/2021	Sell	1,000	$30.23	$30,230.00	57,529
7/1/2021	Sell	1,000	$31.75	$31,750.00
6/14/2021	Sell	2,000	$40.00	$80,000.00	60,529
5/17/2021	Sell	1,000	$19.87	$19,870.00	63,529
4/15/2021	Sell	1,000	$21.14	$21,140.00	63,445
4/1/2021	Sell	1,000	$22.66	$22,660.00
3/15/2021	Sell	1,000	$21.91	$21,910.00	65,445
3/1/2021	Sell	1,000	$18.60	$18,600.00	66,445
2/16/2021	Sell	1,000	$21.81	$21,810.00
2/1/2021	Sell	1,000	$19.99	$19,990.00	66,414
1/15/2021	Sell	1,000	$21.05	$21,050.00	68,245
1/4/2021	Sell	1,000	$19.75	$19,750.00	69,189
12/15/2020	Sell	1,000	$24.55	$24,550.00	70,209
12/1/2020	Sell	1,000	$21.83	$21,830.00	70,938
11/16/2020	Sell	1,000	$20.25	$20,250.00	67,414
10/15/2020	Sell	1,000	$35.76	$35,760.00	65,058
10/12/2020	Sell	2,000	$40.20	$80,400.00	66,058
10/1/2020	Sell	1,000	$31.18	$31,180.00	68,058
9/15/2020	Sell	1,000	$36.14	$36,140.00	66,858
9/1/2020	Sell	1,000	$26.24	$26,240.00	67,858
8/17/2020	Sell	1,000	$24.76	$24,760.00	68,858
8/3/2020	Sell	1,000	$21.54	$21,540.00	69,858
7/15/2020	Sell	1,000	$28.76	$28,760.00	70,858
7/1/2020	Sell	1,000	$28.61	$28,610.00	71,858
6/15/2020	Sell	1,000	$20.95	$20,950.00	72,858
6/1/2020	Sell	1,000	$18.50	$18,500.00	73,858
5/22/2020	Sell	7,500	$18.02	$135,150.00

William Ho Buying and Selling Activity at RAPT Therapeutics

RAPT Therapeutics Company Overview

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company

Today's Range

Now: $1.08

$1.04

$1.12

50 Day Range

MA: $1.84

$1.04

$3.10

2 Week Range

Now: $1.08

$1.00

$27.35

Volume

498,374 shs

Average Volume

1,108,869 shs

Market Capitalization

$37.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Let’s be blunt

From DTI | Ad

Check out the $100 Challenge now

William Ho Biography and Net Worth

What is William Ho's net worth?

How old is William Ho?

What is William Ho's salary?

How do I contact William Ho?

Has William Ho been buying or selling shares of RAPT Therapeutics?

Who are RAPT Therapeutics' active insiders?

Are insiders buying or selling shares of RAPT Therapeutics?